Clinical Trial Update: A First-in-Human Study of XSTEM-OA in Patients With Knee Osteoarthritis [Phase 1, Phase 2]

View source ↗

Summary

A first-in-human study of XSTEM-OA for knee osteoarthritis in Phase 1/2 has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Knee

Drugs mentioned

• XSTEM-OA

Snippet

Sponsor: Xindu Pty Ltd | Conditions: Osteoarthritis, Knee | Phase 1, Phase 2 | Status: COMPLETED